ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Elevance Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026
$430.23+1.97 (+0.46%)
Close on Oct 19, 2026
- Market cap
- $93.75B
- P/E (TTM)
- 19.1
- Dividend yield
- –
Elevance Health, Inc. revenue by segment
By business segment
| Operating income | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reportable Segments | $1.76B | $2.09B | $309.00M | $1.30B | $2.43B | $3.17B | $673.00M | $1.41B | $2.77B | $3.02B | – | – | -27.3% |
| Total Carelon | $948.00M | $1.05B | $574.00M | $775.00M | $936.00M | $1.09B | $568.00M | $803.00M | $705.00M | $813.00M | – | – | +1.3% |
| Health Benefits | $896.00M | $2.16B | -$220.00M | $601.00M | $1.56B | $2.22B | $207.00M | $1.60B | $2.15B | $2.29B | $767.00M | $1.83B | -42.6% |
| CarelonRx | $582.00M | $582.00M | $724.00M | $556.00M | $536.00M | $602.00M | $533.00M | $619.00M | $497.00M | $523.00M | $490.00M | $477.00M | +8.6% |
| Carelon Services | $366.00M | $470.00M | -$150.00M | $219.00M | $400.00M | $491.00M | $35.00M | $184.00M | $208.00M | $290.00M | $102.00M | $192.00M | -8.5% |
| Corporate & Other | -$81.00M | -$1.12B | -$45.00M | -$81.00M | -$71.00M | -$140.00M | -$102.00M | -$999.00M | -$85.00M | -$84.00M | -$75.00M | -$747.00M | +14.1% |
| Segment Eliminations [Member] | – | – | – | – | – | – | – | – | – | – | $0 | $0 | – |
| Corporate & Other Segment | – | – | – | – | – | – | – | – | – | – | -$102.00M | -$741.00M | – |
| Total | – | – | – | – | – | – | – | $803.00M | $705.00M | $813.00M | $592.00M | $669.00M | – |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product revenue | $6.26B | $6.23B | $6.46B | $6.16B | $6.04B | $5.81B | $6.71B | $5.89B | $5.53B | $4.50B | $5.39B | $5.18B | 12.4% | +3.7% |
| Service fees | $2.28B | $2.25B | $2.16B | $2.14B | $2.11B | $2.07B | $2.03B | $2.02B | $2.28B | $2.08B | $1.92B | $2.04B | 4.5% | +8.3% |
By region
From the segment and revenue-disaggregation notes of Elevance Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.